Global Cancer Immunotherapy Market Research Report 2023

Report ID: 2009574 | Published Date: Jan 2025 | No. of Page: 83 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Immunotherapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Immune Checkpoint Inhibitors
        1.2.4 Immune System Modulators
        1.2.5 Cancer Vaccines
    1.3 Market by Application
        1.3.1 Global Cancer Immunotherapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Lung Cancer
        1.3.3 Breast Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Melanoma
        1.3.6 Prostate Cancer
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Immunotherapy Market Perspective (2017-2028)
    2.2 Cancer Immunotherapy Growth Trends by Region
        2.2.1 Cancer Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Immunotherapy Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Immunotherapy Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Immunotherapy Market Dynamics
        2.3.1 Cancer Immunotherapy Industry Trends
        2.3.2 Cancer Immunotherapy Market Drivers
        2.3.3 Cancer Immunotherapy Market Challenges
        2.3.4 Cancer Immunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Immunotherapy Players by Revenue
        3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2017-2022)
        3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Immunotherapy Revenue
    3.4 Global Cancer Immunotherapy Market Concentration Ratio
        3.4.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2021
    3.5 Cancer Immunotherapy Key Players Head office and Area Served
    3.6 Key Players Cancer Immunotherapy Product Solution and Service
    3.7 Date of Enter into Cancer Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Breakdown Data by Type
    4.1 Global Cancer Immunotherapy Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2023-2028)
5 Cancer Immunotherapy Breakdown Data by Application
    5.1 Global Cancer Immunotherapy Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Immunotherapy Market Size (2017-2028)
    6.2 North America Cancer Immunotherapy Market Size by Country (2017-2022)
    6.3 North America Cancer Immunotherapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cancer Immunotherapy Market Size (2017-2028)
    7.2 Europe Cancer Immunotherapy Market Size by Country (2017-2022)
    7.3 Europe Cancer Immunotherapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Immunotherapy Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Immunotherapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cancer Immunotherapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cancer Immunotherapy Market Size (2017-2028)
    9.2 Latin America Cancer Immunotherapy Market Size by Country (2017-2022)
    9.3 Latin America Cancer Immunotherapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Immunotherapy Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Immunotherapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cancer Immunotherapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Cancer Immunotherapy Introduction
        11.1.4 Amgen Revenue in Cancer Immunotherapy Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Detail
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Cancer Immunotherapy Introduction
        11.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2017-2022)
        11.2.5 AstraZeneca Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Cancer Immunotherapy Introduction
        11.3.4 Roche Revenue in Cancer Immunotherapy Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Detail
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Cancer Immunotherapy Introduction
        11.4.4 Bayer Revenue in Cancer Immunotherapy Business (2017-2022)
        11.4.5 Bayer Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Detail
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2017-2022)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Cancer Immunotherapy Introduction
        11.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2017-2022)
        11.6.5 Eli Lilly Recent Development
    11.7 Merck
        11.7.1 Merck Company Detail
        11.7.2 Merck Business Overview
        11.7.3 Merck Cancer Immunotherapy Introduction
        11.7.4 Merck Revenue in Cancer Immunotherapy Business (2017-2022)
        11.7.5 Merck Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Cancer Immunotherapy Introduction
        11.8.4 Novartis Revenue in Cancer Immunotherapy Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Cancer Immunotherapy Introduction
        11.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2017-2022)
        11.9.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Immune Checkpoint Inhibitors
    Table 4. Key Players of Immune System Modulators
    Table 5. Key Players of Cancer Vaccines
    Table 6. Global Cancer Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Cancer Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cancer Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cancer Immunotherapy Market Share by Region (2017-2022)
    Table 10. Global Cancer Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cancer Immunotherapy Market Share by Region (2023-2028)
    Table 12. Cancer Immunotherapy Market Trends
    Table 13. Cancer Immunotherapy Market Drivers
    Table 14. Cancer Immunotherapy Market Challenges
    Table 15. Cancer Immunotherapy Market Restraints
    Table 16. Global Cancer Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cancer Immunotherapy Market Share by Players (2017-2022)
    Table 18. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2021)
    Table 19. Ranking of Global Top Cancer Immunotherapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cancer Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cancer Immunotherapy Product Solution and Service
    Table 23. Date of Enter into Cancer Immunotherapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cancer Immunotherapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Cancer Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cancer Immunotherapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cancer Immunotherapy Revenue Market Share by Application (2017-2022)
    Table 31. Global Cancer Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cancer Immunotherapy Revenue Market Share by Application (2023-2028)
    Table 33. North America Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Cancer Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Cancer Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amgen Company Detail
    Table 44. Amgen Business Overview
    Table 45. Amgen Cancer Immunotherapy Product
    Table 46. Amgen Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 47. Amgen Recent Development
    Table 48. AstraZeneca Company Detail
    Table 49. AstraZeneca Business Overview
    Table 50. AstraZeneca Cancer Immunotherapy Product
    Table 51. AstraZeneca Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 52. AstraZeneca Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Cancer Immunotherapy Product
    Table 56. Roche Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Bayer Company Detail
    Table 59. Bayer Business Overview
    Table 60. Bayer Cancer Immunotherapy Product
    Table 61. Bayer Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 62. Bayer Recent Development
    Table 63. Bristol-Myers Squibb Company Detail
    Table 64. Bristol-Myers Squibb Business Overview
    Table 65. Bristol-Myers Squibb Cancer Immunotherapy Product
    Table 66. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 67. Bristol-Myers Squibb Recent Development
    Table 68. Eli Lilly Company Detail
    Table 69. Eli Lilly Business Overview
    Table 70. Eli Lilly Cancer Immunotherapy Product
    Table 71. Eli Lilly Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 72. Eli Lilly Recent Development
    Table 73. Merck Company Detail
    Table 74. Merck Business Overview
    Table 75. Merck Cancer Immunotherapy Product
    Table 76. Merck Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 77. Merck Recent Development
    Table 78. Novartis Company Detail
    Table 79. Novartis Business Overview
    Table 80. Novartis Cancer Immunotherapy Product
    Table 81. Novartis Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Development
    Table 83. Pfizer Company Detail
    Table 84. Pfizer Business Overview
    Table 85. Pfizer Cancer Immunotherapy Product
    Table 86. Pfizer Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 87. Pfizer Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Immunotherapy Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Immune Checkpoint Inhibitors Features
    Figure 4. Immune System Modulators Features
    Figure 5. Cancer Vaccines Features
    Figure 6. Global Cancer Immunotherapy Market Share by Application in 2021 & 2028
    Figure 7. Lung Cancer Case Studies
    Figure 8. Breast Cancer Case Studies
    Figure 9. Colorectal Cancer Case Studies
    Figure 10. Melanoma Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Others Case Studies
    Figure 13. Cancer Immunotherapy Report Years Considered
    Figure 14. Global Cancer Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Cancer Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Cancer Immunotherapy Market Share by Region: 2021 VS 2028
    Figure 17. Global Cancer Immunotherapy Market Share by Players in 2021
    Figure 18. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2021
    Figure 20. North America Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Cancer Immunotherapy Market Share by Country (2017-2028)
    Figure 22. United States Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Cancer Immunotherapy Market Share by Country (2017-2028)
    Figure 26. Germany Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Cancer Immunotherapy Market Share by Region (2017-2028)
    Figure 34. China Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Cancer Immunotherapy Market Share by Country (2017-2028)
    Figure 42. Mexico Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Cancer Immunotherapy Market Share by Country (2017-2028)
    Figure 46. Turkey Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 50. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 51. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 53. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 54. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Frequently Asked Questions
Cancer Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports